Still others, such as the U.K., China, Korea, and Singapore, have set out to become the epicenters of stem cell research, providing money as well as ethical oversight to encourage the field within carefully drawn bounds.In such varied political climates, scientists around the globe are racing to see which techniques will produce treatments soonest.